Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
New Hampshire Stocks
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Scinai Immunotherapeutics Ltd ADR
(NQ:
SCNI
)
3.551
-0.019 (-0.53%)
Streaming Delayed Price
Updated: 2:25 PM EDT, Sep 5, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Scinai Immunotherapeutics Ltd ADR
< Previous
1
2
3
4
5
Next >
BioMedNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI), Scinai Bioservices Enter MSA with Ayana Pharma
April 08, 2024
Via
Investor Brand Network
Gene Signature Could Predict NSC Lung Cancer Response to Immunotherapy
March 22, 2024
Via
Investor Brand Network
12 Health Care Stocks Moving In Tuesday's After-Market Session
March 12, 2024
Via
Benzinga
BioMedNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Showcasing Services, Meeting with Investors at Upcoming BIO-Europe Spring 2024
March 12, 2024
Via
Investor Brand Network
Potential Complications of Untreated Psoriasis
November 02, 2023
Via
Investor Brand Network
Siteman Cancer Center Starts Offering Novel Cell-Based Immunotherapy Against Melanoma
February 28, 2024
Via
Investor Brand Network
BioMedNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Appoints Liat Halpert as Head of Business Development, Sales
February 13, 2024
Via
Investor Brand Network
The Right to Health During Humanitarian Crises Should Include Noncommunicable Diseases
February 09, 2024
Via
Investor Brand Network
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
February 07, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
February 02, 2024
Via
Benzinga
Scientists Uncover Vital T-Cells in Kids’ Brains That Could Fight Brain Cancers
January 26, 2024
Via
Investor Brand Network
BioMedNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Scientific Research Collaborator Receives Prestigious Louis-Jeantet Prize
January 25, 2024
Via
Investor Brand Network
BioMedNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) CEO Releases Shareholder Letter
January 04, 2024
Via
Investor Brand Network
Shining Spotlight on How Vitiligo Could Be Connected to Other Autoimmune Disorders
January 03, 2024
Via
Investor Brand Network
12 Health Care Stocks Moving In Monday's Pre-Market Session
January 01, 2024
Via
Benzinga
BioMedNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Enters Agreement for Million-Dollar Exercise of Outstanding Warrants
December 29, 2023
Via
Investor Brand Network
BioMedNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Announces January Analyst, Investor Webinar
December 27, 2023
Via
Investor Brand Network
New Research Redefines Pathophysiology of Rheumatoid Arthritis, Paves Way for Precision Treatments
December 20, 2023
Via
Investor Brand Network
BioMedNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Reports on Preclinical Results from Psoriatic Human Skin Trial
December 12, 2023
Via
Investor Brand Network
BioMedNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Announced Peer-Reviewed Journal Publishes Data Supporting NanoAbs
December 11, 2023
Via
Investor Brand Network
Exposures
COVID-19
Many Fellowship Programs for Infectious Disease Specialists Remain Unfilled in US
December 08, 2023
Via
Investor Brand Network
BioMedNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Announces Maturity Extension of EIB Finance Facility
November 29, 2023
Via
Investor Brand Network
Autoimmunity Patients Face Cost, Diagnosis, Care Challenges
November 28, 2023
Via
Investor Brand Network
New, Deadly Infectious Diseases Could Emerge as Climate Change Worsens
November 14, 2023
Via
Investor Brand Network
Topics
Climate Change
Exposures
Climate
BioMedNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Receive $900K IIA Grant for New CDMO Business Unit
November 07, 2023
Via
Investor Brand Network
Topics
Economy
Exposures
Economy
BioMedNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Releases Status Report on NASDAQ Compliance
November 06, 2023
Via
Investor Brand Network
Scinai Immunotherapeutics Announces Award of Non-Dilutive Grant from Israel Innovation Authority Supporting its New CDMO Business Unit
November 06, 2023
From
Scinai Immunotherapeutics Ltd.
Via
GlobeNewswire
Scinai Immunotherapeutics Provides Update Regarding Nasdaq Compliance
November 03, 2023
From
Scinai Immunotherapeutics Ltd.
Via
GlobeNewswire
BioMedNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Releases Q3 2023 Financial Report, Reports Possible Adjustment of Facility Terms by EIB
October 31, 2023
Via
Investor Brand Network
Exposures
COVID-19
European Investment Bank (EIB) considering extending maturity of its financial facility contract with Scinai Immunotherapeutics in light of Scinai’s recent strategic pivot
October 31, 2023
From
Scinai Immunotherapeutics Ltd.
Via
GlobeNewswire
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.